7 results match your criteria: "University of Arizona Medical College[Affiliation]"
J Orthop Trauma
February 2018
The CORE Institute, Center for Orthopedic Research and Education, Banner Musculoskeletal Institute Center Chiefs for Orthopedic Trauma and Bone Health, University of Arizona, College of Medicine, Phoenix.
Objectives: To compare mechanism of injury, fracture pattern, displacement, clinical, and radiographic outcome of isolated acetabular fractures (group 1) versus acetabular fractures associated with a pelvic ring injury (group 2).
Design: Retrospective cohort comparative analysis.
Setting: Private orthopaedic practice associated with a level one teaching trauma center.
J Orthop Trauma
August 2017
*Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD; †Orthopaedic Trauma Service, Wake Forest University Baptist Medical Center, Winston-Salem, NC; ‡Department of Orthopaedic Surgery, McGovern Medical School at UTHealth Houston, Houston, TX; §Department of Orthopaedic Surgery, Methodist Hospital, Indianapolis, IN; ‖Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD; ¶The CORE Institute, University of Arizona Medical College - Phoenix, Banner University Medical Center, Phoenix, AZ; **Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and ††Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Objectives: The impact of the Trauma Collaborative Care (TCC) program on surgeon confidence in managing the psychosocial sequelae of orthopaedic trauma was evaluated as part of a larger prospective, multisite, cluster clinical trial. We compared confidence and perceived resource availability among surgeons practicing in trauma centers that implemented the TCC program with orthopaedic trauma surgeons in similar trauma centers that did not implement the TCC.
Design: Prospective cohort design.
J Orthop Trauma
April 2017
*Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD; †R Adams Cowley Shock Trauma Center, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD; ‡Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; §Inova Fairfax Medical Campus, Department of Orthopaedic Surgery, Orthopaedic Trauma, Fairfax, VA; ‖Department of Orthopaedic Surgery and Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN; ¶The CORE Institute, University of Arizona Medical College - Phoenix, Banner University Medical Center, Phoenix, AZ; **Carolinas Medical Center, Department of Orthopaedic Surgery, Charlotte, NC; and ††Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
J Orthop Trauma
April 2017
*Department of Orthopaedic Surgery and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN; †Hennepin County Medical Center, Minneapolis, MN; ‡Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD; §Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‖Department of Orthopaedic Surgery, UCSF/SFGH Orthopaedic Trauma Institute, University of California, San Francisco, San Francisco, CA; ¶Boston University Medical Center, Boston, MA; **U.S. Army, Uniformed Services University of the Health Sciences, San Antonio Military Medical Center, Infectious Disease Service, San Antonio, TX; ††The CORE Institute, Banner University Medical Center, University of Arizona Medical College, Phoenix, AZ; and ‡‡Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Patients surgically treated for infection after extremity fractures are typically discharged with a 6- to 12-week antibiotic regimen. Intravenous (IV) antibiotics are associated with significant cost and potential complications of deep vein thrombosis, line clotting, and sepsis. Many of the pathogens that cause musculoskeletal infection have both oral (PO) and IV antibiotic options with adequate bioavailability and antibacterial effect, yet IV antibiotics remain the standard of care absent evidence that PO options are clinically as efficacious.
View Article and Find Full Text PDFAm J Surg Pathol
February 2008
Department of Pathology, University of Arizona Medical College, Tucson, AZ 85724, USA.
Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is an oncofetal protein highly expressed in fetal tissue and malignant tumors but rarely found in adult benign tissues. The aim of this study is to determine the expression of IMP3 in benign endometrium, endometrial cancer, and its precursor lesions, trying to see whether IMP3 has any diagnostic usage. Two hundred ninety-eight endometrial samples were examined for IMP3 expression by immunohistochemistry.
View Article and Find Full Text PDFCommunity-acquired pneumonia (CAP) is a leading cause of morbidity and mortality, despite effective therapies. Guidelines for CAP management vary widely in their approach. Resistance of S pneumoniae to penicillins and other antibiotics has prompted evaluation of the new fluoroquinolones.
View Article and Find Full Text PDFEndocrinology
December 1999
Department of Medicine, University of Arizona Medical College, Tucson 85724-5099, USA.
Intracerebroventricular (icv) injection of interleukin-1beta (IL-1beta) in rats induces elevated IL-6 levels in peripheral blood, exceeding those induced by iv or ip injection. Two hypotheses postulated to explain this phenomenon were tested. Mediation by peripheral sympathetic activation was excluded by showing that agents that blocked preganglionic cholinergic synapses (chlorisondamine), beta-adrenergic receptors (propanalol, butoxamine), and alpha-adrenergic receptors (phentolamine) did not prevent the IL-6 response.
View Article and Find Full Text PDF